Test Code PDR Post Delivery Rhogam (Fetal Screen)
Synonyms
- Rosette test
- FMH Screen
Clinical Significance
The use of a test to detect large fetal-maternal hemorrhages is required in AABB standards for blood banks and transfusion services.
Methodology
A suspension of red blood cells from the D-Negative mother is mixed with reagent containing anti-D and is incubated for 5 minutes at room temperature. During incubation any minor population of D-positive cells are coated with anti-D. After incubation cells are washed to remove all unbound antibody and indicator cells are added. One antigen-binding site free to attach to an Rh antigen of the indicator cells. the red cell mixture is centrifuged and examined microscopically for mixed-field agglutination in the form of rosettes at low power. The indicator cells added after washing form rosettes around the individual cells leading to larger agglutinates for detection.
Sample Type
Preferred Sample Type | |
---|---|
Lavender top - Packed RBCs |
Centrifuge: Yes (In Blood Bank)
Specimen Stability
Temperature | Time |
---|---|
Refrigerated (1-10°C) (store) | 48 hours |
Specimen Minimum Volume
0.5 mL
Result Reporting
Normal |
---|
Negative |
Abnormal |
---|
Positive* |
*Positive fetal screens reflex to a Kleihauer Betke
Rejection Criteria
- Samples not properly labeled (2 patient identifiers required)
- Grossly hemolyzed specimens
Availability
Performed | STAT |
---|---|
24/7 | Yes |
Performing Laboratory
MultiCare Yakima Memorial Hospital Laboratory
Lab Department
Blood Bank
CPT Code
85461
LOINC
33900-2 Fetal cell screen Rosette test QI (Bld)